ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
This study has been withdrawn prior to enrollment.
(Lack of accrual)
Tulane University Health Sciences Center
First Posted: October 12, 2009
Last Update Posted: March 13, 2017
Board of Regents, State of Louisiana
Information provided by (Responsible Party):
Bridgette Collins-Burow, Tulane University
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||December 2010|
|Primary Completion Date:||September 2010 (Final data collection date for primary outcome measure)|